Jonathan Maybaum
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Cancer Research top 5%
Papers in
-
- Cancer Genomics and Diagnostics 11
- Oncology 39
- Cancer-related Molecular Pathways 15
- Colorectal Cancer Treatments and Studies 10
- PARP inhibition in cancer therapy 8
- Pancreatic and Hepatic Oncology Research 8
- Co-authors
- Theodore S. LawrenceLeslie A. ParselsMeredith A. MorganMary A. DavisJoshua D. ParselsChristine E. CanmanLili ZhaoDaniel P. Normolle
- Journals
- Cancer Research (8 papers)Clinical Cancer Research (7 papers)International Journal of Radiation Oncology*Biology*Physics (5 papers)Radiation Research (4 papers)Molecular Pharmacology (4 papers)
- Partner nations
- United StatesBrazilNew Zealand
In The Last Decade
Jonathan Maybaum
79 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 111
- Oncology 1.8k
- Cancer Research 590
- Molecular Biology 2.4k
- Biotechnology 130
- Pulmonary and Respiratory Medicine 446
Countries citing papers authored by Jonathan Maybaum
This map shows the geographic impact of Jonathan Maybaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Maybaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Maybaum more than expected).
Fields of papers citing papers by Jonathan Maybaum
This network shows the impact of papers produced by Jonathan Maybaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Maybaum. The network helps show where Jonathan Maybaum may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Maybaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 98 | |
| 2 | 2016 | 50 | |
| 3 | 2014 | 125 | |
| 4 | 2013 | 89 | |
| 5 | 2013 | 80 | |
| 6 | 2012 | 73 | |
| 7 | 2011 | 67 | |
| 8 | 2010 | 249 | |
| 9 | 2010 | 26 | |
| 10 | 2009 | 120 | |
| 11 | 2008 | 99 | |
| 12 | 1998 | 10 | |
| 13 | 1998 | 22 | |
| 14 | 1994 | 60 | |
| 15 | 1993 | 20 | |
| 16 | 1992 | 11 | |
| 17 | 1991 | 13 | |
| 18 | 1991 | 39 | |
| 19 | 1991 | 9 | |
| 20 | Tissue-specific pharmacodynamics of 5-bromo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits. | 1988 | 10 |
About Jonathan Maybaum
Jonathan Maybaum is a scholar working on Cancer Research, Oncology, Molecular Biology, Infectious Diseases and Hepatology, having authored 79 papers that have together received 3.6k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (30 papers), Cancer-related Molecular Pathways (15 papers), Cancer Genomics and Diagnostics (11 papers), Biochemical and Molecular Research (10 papers), Colorectal Cancer Treatments and Studies (10 papers), Cancer therapeutics and mechanisms (10 papers), PARP inhibition in cancer therapy (8 papers) and Pancreatic and Hepatic Oncology Research (8 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (590 citations), Molecular Biology (2.4k citations), Biotechnology (130 citations) and Pulmonary and Respiratory Medicine (446 citations). Jonathan Maybaum has collaborated with scholars based in United States, Brazil and New Zealand. Frequent co-authors include Theodore S. Lawrence, Leslie A. Parsels, Meredith A. Morgan, Mary A. Davis, Joshua D. Parsels, Christine E. Canman, Lili Zhao, Daniel P. Normolle, Wolfgang Sadée and Joseph Golbus. Their work appears in journals such as Cancer Research, Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics, Radiation Research and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.